Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut: chairman

Q: How long will it take to read this news story?

The story "Celltrion seeks large-scale M&amp;A in Q4, eyes 2027 Nasdaq debut: chairman" has 489 words across 25 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Celltrion seeks large-scale M&amp;A in Q4, eyes 2027 Nasdaq debut: chairman" was covered 5 hours ago by Korea Economic Daily, a news publisher based in South Korea.

Q: How trustworthy is 'Korea Economic Daily' news outlet?

Korea Economic Daily is a fully independent (privately-owned) news outlet established in 1964 that covers mostly economy news. The outlet is headquartered in South Korea and publishes an average of 10 news stories per day. It's most recent story was published ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #25185012</li><li>URL: https://beamstart.com/news/celltrion-seeks-large-scale-ma-17369949698538</li></ul>

Korea Economic Daily Logo Korea Economic Daily 5h ago

Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut: chairman - Korea Economic Daily

Quick Summary:

At the JP Morgan presentation, Seo Jin-seok, chief executive of Celltrion Inc.and Chairman Seo’s eldest son, unveiled development schedules for 13 new drug candidates as part of its bid to transition from a biosimilar-focused company to a major player in new drug development.“Four new drug candidates will sequentially enter clinical trials this year.

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc.seeks to acquire a domestic health food maker as early as the fourth quarter and plans to list its investment holding firm, Celltrion Holdings Co., on the Nasdaq in 2027.

Celltrion founder and Chairman Seo Jung-jin said the company Celltrion is looking at for acquisition is in the health functional food industry.“By the fourth quarter, the domestic stock market will have recovered from its low, creating favorable conditions for an M&A.